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What is already known on this subject 
Illicit drug use in adolescence has previously been shown to be associated with an increased 
risk of drug use, delinquency, violence and poor mental health during adulthood. 
 
Few studies have examined associations between adolescent illicit drug use with adult social, 
economic, and criminal justice outcomes.  
 
What this study adds 
We found new links between illicit drug use in adolescence and an increased risk of 
experiencing homelessness, being arrested and/or cautioned by the police, and being found 
guilty at court. These associations were not explained by parental socioeconomic status or 
psychological morbidity in adolescence. 
 
Illicit drug use in adolescence may contribute to the development of health and economic 
inequalities in the transition to adulthood.  
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Abstract 
Background: Illicit drug use in adolescence has been linked to drug use and poor mental 
health in adult life, but few studies have examined the relation with adult economic and 
criminal justice outcomes. 
Methods: We analysed data from 14,082 participants (6,999 women) in the 1970 British 
Birth Cohort Study with data at 16 and 30 years of age. Illicit drug use over study members’ 
lifetime and in the past year were self-reported at 16-years of age. Thirteen outcomes were 
self-reported at 30-years of age, including illicit drug use, smoking, problems with alcohol, 
mental and physical health, experience of socioeconomic disadvantage, and experiences with 
the criminal justice system.   
Results:  At 16 years of age, 20.3% of participants had ever tried an illicit drug and 7.2% had 
used in the past year. After adjustment for parental socioeconomic status and childhood 
mental health problems, and following correction for multiple testing, there was a dose-
response association between illicit drug use at 16-years with illicit drug use in adult life the 
past year (odds ratio; 95% confidence interval: 1.83, 1.51 to 3.12), experiencing 
homelessness (1.74, 1.16 to 2.62), being arrested (1.57, 1.29 to 1.92) and cautioned (1.97, 
1.50 to 2.57) by the police, and being found guilty at court (1.73, 1.34 to 2.23).  
Conclusions: Illicit drug use in adolescence may contribute to the development of health and 
social inequalities in early adulthood. 
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Introduction 
 
Illicit drugs use in adolescence has been well-examined in the context of later drug use1 2 and 
mental health.3 4 5 Studies of twins discordant for cannabis use (i.e. one used cannabis and the 
other did not) suggest a casual relation with later other illicit drugs,6 7 and systematic reviews 
report that regular cannabis use is associated with incident anxiety and mood disorders,2 4 and 
psychosis.8 9 Less well understood is the impact of adolescent drug use on socioeconomic 
adversity and criminal justice outcomes. In the few studies conducted, early-onset cannabis 
use has been linked to poor educational achievement,10 11 delinquency and violence.12 In the 
Victoria Adolescent Health Cohort Study, amphetamine use by 18 years of age was 
associated with increased risks for leaving with no qualifications, but not with 
unemployment, or receiving government benefits at 24-years.5 The potential confounding 
effect of early socioeconomic adversity was not accounted for in these analyses and the role 
of psychological problems has also rarely been considered. Accordingly, we examined 
whether illicit drug use at 16-years of age is associated with an increased risk of an array of 
outcomes at 30 years, including poor health, socioeconomic disadvantage and experiences 
with the criminal justice system.  
 
Methods 
We used data from the 1970 British Birth Cohort Study, an ongoing longitudinal study of 
children born in Great Britain between the 5th and 11th April 1970.  A total of 16, 571 babies 
born in England, Scotland and Wales were enrolled at birth and have been followed up on 
eight occasions across the life course. For the purposes of the present analyses, we used data 
from enquiries about illicit drug taking at 16 years of age, the first occasion these were 
collected.13 Study follow-up was at age 30 years. Parents of study participants gave written 
informed consent. This manuscript adheres to the guidelines for STrengthening the Reporting 
of OBservational studies in Epidemiology (STROBE).14 
 
Study participants 
At the age of 16 (1986), a national teachers strike and school examinations reduced study 
member participation.15 Of the 15,999 members traced and invited to participate, information 
5 
 
was obtained from 11,615 (72.6%). At the age of 30, 14,087 members were traced and 
invited to participate and 11,261 (68%) responded. Preliminary analyses showed there was 
very little difference in the prevalence of illicit drug use at 16-years among those who did and 
did not participate in the survey at 30-years (7.0% vs. 7.2%).  
 
Assessment of illicit drug use at age 16 years 
Exposures, assessed at 16-years of age, were derived from questions asking, “Have 
you ever tried taking cannabis?” (repeated for glue/solvents, amphetamines, barbiturates, 
cocaine, heroin and lysergic acid diethylamide (LSD)). Street names of drugs were also 
provided. Responses were combined across drugs and categorised into: never, taken but not 
in the past year, and taken in the past year.  
 
Outcome assessment at age 30 years 
Thirteen outcomes were chosen from the assessment at 30-years. These were chosen 
to test associations across a number of health and economic domains. Health behaviours 
comprised illicit drug use (ever and in the past year), including the use of cannabis, cocaine, 
crack, ecstasy, amphetamines, poppers, temazepam, ketamine, magic mushrooms, LSD, 
heroin, methadone, and other drugs. Street names of drugs were provided. All participants, 
apart from lifelong teetotallers, were asked to complete questions on possible problems with 
alcohol using the cutting down, being annoyed by criticism, feeling guilty, and eye-openers 
(CAGE) questionnaire.16 Smoking every day was defined as smoking at least one cigarette 
every day in the past week. Mental health problems were assessed using enquiries on: having 
seen a specialist medical provider since age 16 because of a problem with illicit drugs; a 
mental health problem; or a psychological morbidity based on a score of  ≥7 on the Rutter 
Malaise Inventory.17 Physical health was ascertained from self-reports of accidents that 
occurred since 16-years that required treatment by a doctor. These included a sub-set that 
were due to a mugging or a violent or sexual assault. Socioeconomic disadvantage was based 
on employment status and whether participants had been homelessness since 16-years. 
Finally, study members reported having been arrested, formally cautioned or found guilty in a 
court since 16-years of age.  
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Covariates 
Covariates, identified a priori, were chosen based on previous studies showing an 
association with adolescent and/or adult illicit drug use. At 16-years of age these included the 
number of units of alcohol consumed in the past week, smoking in the past week,  
psychological morbidity (score of  ≥7 on the Rutter Malaise inventory),17 and occupational 
social class based on mother’s and father’s occupation provided by parents at interview and 
coded using the Registrar General’s classification system.18  
 
Statistical methods 
We took two approaches to dealing with missing data. The primary approach was to impute 
all missing exposure, outcome and covariate data (MI) using information from over 40 
variables associated with our measures or missingness to make the assumption that data were 
‘missing at random’ more plausible. We conducted a sensitivity analysis using multiple 
imputation then deletion (MID) whereby exposure, outcome and covariate data are imputed, 
but outcome is then deleted before analysis. MID has been found to produce more precise 
estimates than MI and can help minimize bias if the model for imputing outcome data is mis-
specified (i.e., because imputed outcome data are removed before analysis). 19 For both MI 
and MID we generated 20 imputed datasets.  
We compared the characteristics of participants with and without complete data. 
Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals 
(CI) to summarize the association between illicit drug use at 16-years of age and later 
outcomes. In preliminary analyses, there was no difference in results in men and women so 
data were pooled and sex-adjusted. Illegal drug use at 16-years was modelled as a binary 
variable (never vs. use in the past year), or as a categorical variable (never vs. taken but not in 
the past year, used in the past year). The primary analysis was the testing of dose-response 
associations by modelling the categorical drug use exposure variable as a linear term. To 
reduce the risk of generating spurious findings due to multiple testing we applied the 
Bonferroni correction to the tests of trend across categories of drug use.20 This meant that 
only p-values for a test of trend of <0.004 (p=0.05/13) were considered significant. Odds 
ratios were adjusted for sex, parental social class and the Rutter Malaise Inventory and at 16 
year, plus the baseline status of the outcome variable if it was available at 16-years. All 
analyses were performed using Stata, version 15.1. 
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Results 
There were 14,082 participants who provided data at either 16 or 30 years of age. The MID 
sample with complete outcome data was 9,651 and with complete exposure, outcomes and 
covariates was 1,858. Participants with complete data were more likely at 16 years to be 
female, have parents with a managerial or professional occupation, seen a doctor for a mental 
health problem, have a psychological morbidity, have had an accident and less likely to have 
used an illicit drug (ever, or in the past year), seen a specialist or been to a hospital because of 
a drug problems, been homeless, or had any police/criminal justice experiences, than those 
who did not have complete data. Our primary results are based on analyses with the MI 
sample as they offered greater precision (n = 14,082 participants; 6,999 women).  
At 16-years, 20.3% of participants had ever tried an illicit drug, with 7.2% having 
used in the past year. Out of those who used in the past year, 87.0% only used cannabis. Of 
the 13 outcomes studied, after adjustment for confounding factors, adolescent illicit drug use 
was associated with all adult outcomes measured except for having possible problems with 
alcohol, getting treatment for an accident, or being unemployed (Figure). After correction for 
multiple testing, there was a significant linear trend across categories of illicit drug use for 
five outcomes at 30-years of age: illicit drug use in the past year, having been homeless, 
arrested, formally cautioned and found guilty in a court (Table 1). Sensitivity analysis using 
the MID sample (online supplementary tables 1 and 2) and the sample with no missing data 
were not materially different to those using the MI sample (online supplementary tables 3 and 
4). As there were no participants in the sample with no missing data who had seen a specialist 
with a problem with drugs, were unemployed, or been homeless we could not generate 
estimates for these outcomes.  
 
Discussion 
In this population-wide birth cohort study, illicit drug use during adolescence was 
associated with a wide range of adverse outcomes in early adulthood. These included an 
association with illicit drug use in the past year, having been homeless, and criminal justice 
experiences. These associations were not explained by parental socioeconomic status or 
psychological morbidity in adolescence. 
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Comparison with existing studies 
Our analyses examined illicit drug use but replicate those from smaller cohort studies 
that have investigated cannabis and amphetamine use in the United States, New Zealand and 
Australia. These studies have shown that cannabis use in adolescence is associated with 
negative outcomes across a number of domains, including drug use in early adulthood,1 2 
daily smoking, 12 alcohol use disorders,3 mental health problems3 4 21 (in particular cannabis 
with psychosis22 and psychotic disorders 23) and involvement in criminal activity.12 24 They 
replicate the findings of the Victoria Adolescent Health Cohort Study showing amphetamine 
use in adolescence was associated with daily smoking, alcohol dependency, drug use in the 
past year, and psychological distress in early adulthood. 25 Our findings extend these by 
showing that after adjusting for early life socioeconomic disadvantage and multiple 
comparisons there was an association between adolescent drug use with being homeless and 
being convicted in a criminal court.  
 
Potential mechanisms 
The associations between drug use and adult outcomes we observed might be direct, indirect 
or due to confounding. In support of a direct effect, discordant twin studies have found the 
cannabis using twin was more likely to use other illicit drugs at a later date, 6 7 and report 
psychotic like experiences,26 than the twin who did not. In the Christchurch birth cohort, 
associations between cannabis use with juvenile offending were attenuated after adjusting for 
affiliation with substance using or delinquent peers. 24 In the present submission, criminal 
justice experiences might be acting as a mediator by increasing time with delinquent or older 
peers in whom drug use may be more prevalent. This may in-turn lead adolescents to taking 
drugs themselves. An alternative explanation is that these associations are brought about by 
confounding, whereby both adolescent drug use and later adulthood outcomes share common 
antecedents such as conduct/oppositional disorders,24 delinquency,12 and peer 27 or parental 
drug use.28 This explanation suggests illicit drug use is better characterised as a marker rather 
than a cause of a life trajectory that is more likely to experience substance misuse, 
homelessness, the criminal justice system and poor mental health in later life.  
 
Strengths and limitations 
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This study has several strengths, including the wide range of outcomes available, 
extended follow-up into early adulthood, and the wealth of potential confounding factors that 
we adjusted for in our analyses. The main limitation of this study is loss to follow-up and 
missing data. These may have introduced selection bias into the complete case sample. We 
therefore used multiple imputation to minimise this bias. Sensitivity analysis comparing the 
results from the complete case to the imputed datasets provided no evidence that missing data 
introduced bias. The sensitive nature of reporting illicit drug use and police and criminal 
justice experiences may have resulted in under-reporting. In 2004, the UKs 1971 Misuse of 
Drugs Act was amended introducing discretionary warnings for cannabis possession. As drug 
use was reported in the present cohort in 1986, it is possible that cases of cannabis possession 
now would not result in the criminal justice outcomes we observed.  
 
Conclusions 
We found illicit drug use in adolescence is associated with significant socioeconomic 
adversity and poorer health outcomes in adulthood. If causal, these associations would 
suggest that illicit drug use in adolescence contributes to the development of health and 
economic inequalities in the transition to adulthood.  
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Figure. Odds ratios (95% confidence intervals) for adult outcomes of lifetime illicit drug use in adolescence (n = 14, 082) 
 Reference category was never used illicit drugs. Odds ratios (ORs) are adjusted for sex, parental social class and the Rutter Malaise Inventory 
and at 16 years. When available, age 16-year (baseline) assessments of outcomes were added to multivariable models. This included adjusting 
for screening positive on the Rutter Malaise Inventory at 16 years for the outcome at 30-years of having seen a specialist for a psychiatric 
14 
 
problem; units of alcohol consumed in the past week at 16 years for the outcome at 30-years of screening positive for alcohol dependency; and 
the number of cigarettes smoked per week at 16 years for the outcome at 30-years of smoking every day.   
15 
 
Table 1. Odds ratios (95% confidence intervals) for adult outcomes of illicit drug use in adolescence (n = 14, 082) 
a Reference category was never used illicit drugs. Odds ratios (ORs) are adjusted for sex, parental social class and the Rutter Malaise 
Inventory and at 16 years. When available, age 16-year (baseline) assessments of outcomes were added to multivariable models. This 
included adjusting for screening positive on the Rutter Malaise Inventory at 16 years for the outcome at 30-years of having seen a specialist for 
a psychiatric problem; units of alcohol consumed in the past week at 16 years for the outcome at 30-years of screening positive for alcohol 
dependency; and the number of cigarettes smoked per week at 16 years for the outcome at 30-years of smoking every day.   
 
 Illicit drug use at 16 years  
Outcome at 30 years a Never  Taken but not in past 
year 
Taken in past year P-value for 
trend 
Health behavior 
    
  Illicit drug use in the past year 1 (Reference) 1.57 (1.27, 1.94) 2.36 (1.80, 3.09) <0.001 
  Smoke every day 1 1.20 (0.93, 1.54) 1.52 (1.10, 2.12) 0.02 
  Alcohol problem (CAGE score ≥2) 1  1.17 (0.86, 1.58) 1.59 (1.10, 2.26) 0.02 
Mental health  
    
  Seen specialist for problem with illicit drugs since 16 
years of age 
1 1.63 (0.86, 3.10) 2.71 (1.22, 6.01) 0.01 
  Seen specialist for psychiatric problem since 16 
years of age 
1  1.19 (1.01, 1.40) 1.22 (0.94, 1.60) 0.03 
  Psychiatric morbidity (Malaise score ≥7) 1  1.35 (1.09, 1.67) 1.31 (1.00, 1.72) 0.01 
Physical health  
    
  Seen doctor since 16 years of age to get treatment 
for an accident 
1  1.03 (0.88, 1.20) 1.00 (0.83, 1.22) 0.88 
  Seen doctor since 16 years of age to get treatment 
for a violent assault, mugging or sexual assault  
1  1.27 (0.99, 1.63) 1.27 (0.90, 1.80) 0.03 
Socioeconomic disadvantage 
    
  Unemployed 1  1.24 (0.74, 2.08) 1.27 (0.68, 2.37) 0.36 
  Homeless since 16 years of age 1  1.54 (1.04, 2.29) 2.11 (1.32, 3.37) 0.002 
Police/ criminal justice experiences 
    
  Arrested by police since 16 years  1  1.55 (1.23, 1.94) 1.63 (1.23, 2.17) <0.001 
  Formally cautioned by police since 16 years  1  1.74 (1.34, 2.25) 2.41 (1.59, 3.63) <0.001 
  Been found guilty in court since 16 years  1  1.53 (1.15, 2.04) 2.12 (1.59, 2.83) <0.001 
